151 related articles for article (PubMed ID: 37227470)
1. Secretory carcinoma of the salivary gland is rich in lactoferrin: a possible lactational-like differentiation?
Custódio M; Nunes FD; Altemani A; Passador-Santos F; Rodrigues MFSD; de Sousa SCOM; Sedassari BT
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3891-3896. PubMed ID: 37227470
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathologic and molecular genetic analysis of secretory carcinoma of salivary gland].
Zhao M; Zhao DH; Cheng G; Yan YJ; Wang Z; He XL
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Aug; 53(8):533-538. PubMed ID: 30078266
[No Abstract] [Full Text] [Related]
3. Expression of upstream and downstream targets of mTOR pathway in seven cases of secretory carcinoma of salivary gland origin.
Custódio M; Sedassari BT; Altemani A; Rodrigues MFSD; Nunes FD; de Sousa SCOM
Eur Arch Otorhinolaryngol; 2021 Jan; 278(1):279-283. PubMed ID: 32577896
[TBL] [Abstract][Full Text] [Related]
4. MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics.
Taverna C; Baněčková M; Lorenzon M; Palomba A; Franchi A; Skalova A; Agaimy A
Histopathology; 2021 Sep; 79(3):315-324. PubMed ID: 32931030
[TBL] [Abstract][Full Text] [Related]
5. Lysozyme Expression Can be Useful to Distinguish Mammary Analog Secretory Carcinoma from Acinic Cell Carcinoma of Salivary Glands.
Mariano FV; Gómez CA; de Souza do Nascimento J; Dos Santos HT; Egal ES; Montalli VA; Vargas PA; de Almeida OP; Altemani A
Head Neck Pathol; 2016 Dec; 10(4):429-436. PubMed ID: 27177644
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase VI: a novel marker for salivary serous acinar differentiation and its application to discriminate acinic cell carcinoma from mammary analogue secretory carcinoma of the salivary gland.
Hsieh MS; Jeng YM; Jhuang YL; Chou YH; Lin CY
Histopathology; 2016 Apr; 68(5):641-7. PubMed ID: 26212680
[TBL] [Abstract][Full Text] [Related]
7. Mammary analogue secretory carcinoma of salivary glands is a lipid-rich tumour, and adipophilin can be valuable in its identification.
Mariano FV; dos Santos HT; Azañero WD; da Cunha IW; Coutinho-Camilo CM; de Almeida OP; Kowalski LP; Altemani A
Histopathology; 2013 Oct; 63(4):558-67. PubMed ID: 23931576
[TBL] [Abstract][Full Text] [Related]
8. [Secretory carcinoma of salivary gland: a clinicopathological and prognostic analysis of twelve cases].
Cao YS; Lyu XQ
Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):899-903. PubMed ID: 34344073
[No Abstract] [Full Text] [Related]
9. Mist1: a novel nuclear marker for acinic cell carcinoma of the salivary gland.
Hsieh MS; Jeng YM; Lee YH
Virchows Arch; 2019 Nov; 475(5):617-624. PubMed ID: 31187185
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactive prolactin in lesions and tumours of salivary glands.
Ninomiya T; Orito T; Tsukitani K; Mori M; Imanishi Y
Acta Histochem; 1988; 84(1):41-50. PubMed ID: 3146854
[TBL] [Abstract][Full Text] [Related]
11. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
[TBL] [Abstract][Full Text] [Related]
12. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.
Bell D; Ferrarotto R; Liang L; Goepfert RP; Li J; Ning J; Broaddus R; Weber RS; El-Naggar AK
Virchows Arch; 2020 Feb; 476(2):295-305. PubMed ID: 31423558
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Evaluation Of Oestrogen Receptors In Adenoid Cystic Carcinoma Of Salivary Gland.
Mujtaba H; Atique M; Batool I; Umer MF
J Ayub Med Coll Abbottabad; 2017; 29(4):535-539. PubMed ID: 29330972
[TBL] [Abstract][Full Text] [Related]
14. Utility of an immunocytochemical analysis for pan-Trk in the cytodiagnosis of secretory carcinoma of the salivary gland.
Ito H; Ishida M; Ebisu Y; Okano K; Sandoh K; Noda Y; Miyasaka C; Fujisawa T; Yagi M; Iwai H; Tsuta K
Diagn Cytopathol; 2021 Aug; 49(8):E329-E335. PubMed ID: 33885200
[TBL] [Abstract][Full Text] [Related]
15. The morphological spectrum of salivary gland type tumours of the breast.
Foschini MP; Morandi L; Asioli S; Giove G; Corradini AG; Eusebi V
Pathology; 2017 Feb; 49(2):215-227. PubMed ID: 28043647
[TBL] [Abstract][Full Text] [Related]
16. Cytopathological features of secretory carcinoma of salivary glands and ancillary techniques in its diagnostics: impact of new Milan system for reporting salivary gland cytopathology.
Miesbauerová M; Tommola S; Šteiner P; Baněčková M; Skálová A; Kholová I
APMIS; 2019 Jul; 127(7):491-502. PubMed ID: 30942913
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
Hung YP; Jo VY; Hornick JL
Histopathology; 2019 Jul; 75(1):54-62. PubMed ID: 30801752
[TBL] [Abstract][Full Text] [Related]
18. MUC1, MUC2, MUC4, and MUC5AC expression in salivary gland mucoepidermoid carcinoma: diagnostic and prognostic implications.
Handra-Luca A; Lamas G; Bertrand JC; Fouret P
Am J Surg Pathol; 2005 Jul; 29(7):881-9. PubMed ID: 15958852
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein-related peptidase 10 expression in salivary gland tissues and tumours.
Darling MR; Hashem NN; Zhang I; Mohamed AB; Fung K; Kwan K; Mara TW; Daley TD; Diamandis EP
Int J Biol Markers; 2012 Dec; 27(4):e381-8. PubMed ID: 23250777
[TBL] [Abstract][Full Text] [Related]
20. Migration-stimulating factor as a novel biomarker in salivary gland tumours.
Aljorani LE; Bankfalvi A; Carey FA; Harada K; Ohe G; Jones SJ; Ellis IR; Schor SL; Schor AM
J Oral Pathol Med; 2011 Nov; 40(10):747-54. PubMed ID: 21481007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
